Allergy Immunotherapy Market Size, Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Spain, Italy, Japan, China, India, Brazil, Mexico, South Africa, Saudi Arabia), Application Potential, Price Trends, Competitive Market Share & Forecast, 2021 – 2027
Report ID: GMI4298
Allergy Immunotherapy Market size is projected to experience significant growth from 2019 to 2025.
Allergy is a response stimulated by immune system to foreign substances, known as allergens, that are typically not harmful to the body. Common allergens are pollen, pet dander, certain food items and sometimes some metals and even insects. Red eyes, itchy rashes, cold, swelling, shortness of breath and sneezing are few of the allergic symptoms. To avoid further complications and adverse conditions, immunotherapy treatment is adopted to treat allergic reactions. Allergy immunotherapy is hypo-sensitization or desensitization medical treatment for allergies. Measured doses of allergens are given to the patient causing the immune system to become less sensitive to the substance by blocking antibody function, resulting in reduced inflammation.
Allergy Immunotherapy Market, By Type of Allergy
Get more details on this report - Request Free Sample PDF
Increasing number of patients with allergies worldwide will augment the allergy immunotherapy business growth in the coming years. According to the European Academy of Allergy and Clinical Immunology, more than 1 billion people are affected by allergic diseases worldwide. Changing environmental and lifestyle factors affects immune system of people adversely. Thus, with growing awareness about allergy immunotherapy, and regular medical check-up will boost allergy immunotherapy business growth in the forthcoming period.
People with family history of asthma or allergies such as hives or eczema and hay fever are most likely to develop allergy. In such scenario, patient needs to adopt preventive approach by avoiding exposure to certain allergens and undergoing treatment to possibly limit the symptoms. The Food Allergy Research and Education stated that nearly 32 million Americans have food allergies. Food allergies can be serious and life threatening. Thus, rising awareness among patients about allergens and therapeutic treatments will further assist allergy immunotherapy market growth in the forthcoming years.
Rising investment in allergy immunotherapy industry will positively impact industry growth. In November 2018, Stallergenes Greer announced the U.S. FDA approval of Oralair Sublingual Immunotherapy tablet for the treatment of grass pollen allergy. This medicine is used to treat patients aged between 5-9 years. However, stringent and changing regulatory policies may impede allergy immunotherapy industry growth to certain extent over the forthcoming years.
Subcutaneous immunotherapy (SCIT) segment will hold a significant revenue size over the forecast years. Better affordability and availability of allergy shots will increase the demand for SCIT over the forthcoming years. They are widely used for the treatment of allergy affecting nose, eyes and ears, as well as patient suffering from asthma and severe insect sting allergies. SCIT is a proven treatment that has been in use for over 100 years. Convenient and quick purchasing of allergy shots from pharmacies will further escalate the customer preference and adoption, thereby stimulating segmental growth.
Allergy rhinitis market will progress at a significant pace over the projected timeframe. Rising prevalence of hay fever (allergic rhinitis) across the globe will boost the market growth. According to the American Academy of Allergy, Asthma and Immunology (AAAAI), nearly 7.8% of people aged 18 years and above in the U.S. have allergy rhinitis. Worldwide, around 30% of the total population are affected by hay fever annually. Thus, growing infection rate and adoption of advanced treatment methods will highly impact allergy immunotherapy market revenue share over the upcoming years.
The distribution of allergy immunotherapy through pharmacies will witness lucrative growth in the upcoming years. Due to frequent cases of allergy and easy availability of drugs and allergy shots, pharmacies segment is expected to witness robust growth in the future. Owing to cost-effective price of drugs in pharmacies, the segment will witness higher customer preference for the purchase of allergy immunotherapy. Additionally, expanding number of pharmacies in emerging countries will spur the growth of the segment.
Europe allergy immunotherapy market will foresee momentous expansion owing to increasing prevalence of allergy, presence of accessible distribution channel and favorable regulatory framework in the region. According to the International Study of Asthma and Allergies in Childhood (ISAAC), around 20% of children in European region suffer from hay fever. Additionally, high awareness and increasing need of advanced treatments will further pose lucrative business growth opportunity in the foreseeable future.
India allergy immunotherapy market will foresee momentous growth due to increasing prevalence of allergies and rising awareness among people about advanced immunotherapies. Allergies are very common in India caused by various factors resulting into pain, discomfort and irritation. In India, around 20-30% of the total population possess more than one allergy. Formation of proper regulatory scenario for sale of drugs through online pharmacies will additionally boost allergy immunotherapy business growth and development.
Some of the major market players involved in the global allergy immunotherapy market are Merck, Heska, Biodiagnostic, and ALK. Firms are adopting business expansion strategies and collaborations and new product development to increase their market footprint. For instance, in June 2019, ALK announced European approval for tree SLIT-tablet for allergic rhinitis. This strategy will help the company in strengthening its market position by geographical expansion.
Allergy Immunotherapy Market, By Treatment, 2014-2025 (USD Million)
- Subcutaneous Therapy (SCIT)
- Sublingual Therapy (SLIT)
Allergy Immunotherapy Market, By Type of Allergy, 2014-2025 (USD Million)
- Allergic rhinitis
- Allergic conjunctivitis
- Allergic asthma
- Stinging insect venom
Allergy Immunotherapy Market, By Distribution Channel, 2014-2025 (USD Million)
The above information is provided for the following regions and countries:
- North America
- Asia Pacific
- Latin America
- Middle East and Africa
- South Africa
- Saudi Arabia
- Allergan plc.
- Sallergenes Greer
What Information does this report contain?
Customize this Report
Our Market Research Reports Include:
- Market snapshot
- Market Segmentation
- Value Chain Analysis
- Growth Dynamics
- Potential Market Opportunities
- Regulatory Overview
- Technology Evolution
- Innovation & Sustainability
Benefits of Association
Data Coverage & Quality
GMI reports provide the most comprehensive coverage of any focus industry, ensuring a holistic and deep understanding of the market, along with actionable and granular data. We also take pride in our commitment to quality and strive to ensure that our clients get their moneys worth.
Client Trust & Security
GMI maintains strict code of conduct as a business and is committed to ensure that the privacy and trust of our clients are always maintained. As an organization, we also strive to be fully compliant with privacy laws, PCI and information security guidelines.
Our customers rely on us to produce accurate, reliable and timely information. Service orientation is a key mission for us as an organization; our process is guided by the desire to ensure that our clients are provided the best possible solutions in optimal timeframe. GMI stands by its commitment to service, providing timely assistance in both pre-sales and post-sales support for our clients.